Dilantin-30 side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Blood albumin decreased
2. Blood alkaline phosphatase nos increased
3. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
4. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
5. Alanine aminotransferase increased
6. Arthralgia (joint pain)

male:

1. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
2. Anticonvulsant drug level below therapeutic
3. Benign prostatic hyperplasia (benign enlargement of the prostate)
4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
5. Difficulty in walking
6. Epistaxis (bleed from the nose)
7. Erectile disturbance
8. Renal cell carcinoma stage unspecified (kidney cancer in unknown stage)

0-1:

n/a

2-9:

n/a

10-19:

1. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

20-29:

n/a

30-39:

1. Alanine aminotransferase increased
2. Blood alkaline phosphatase nos increased

40-49:

n/a

50-59:

n/a

60+:

1. Anticonvulsant drug level below therapeutic